SEC Form 4 · accession 0001600132-18-000005
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Deborah Quinn
Officer — Chief Medical Officer
Period of report
Jan 4, 2018
Accepted (ET)
Jan 8, 2018 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2018 | F | 33,114 | $2.49 | D | 75,054 | D |
Table II — derivative securities
No Table II lines on this filing.